For example, genetic reduction of Vps35 in mouse models increases the production of β-amyloid peptide (Aβ) (a key pathological factor of AD), synaptic dysfunction, impairs mitochondrial dynamics and function, and induces memory and cognitive deficits [16,26,28,29]. Here, VPS35 is linked to Alzheimer disease.